Correlation Between Active Biotech and Swedish Orphan
Can any of the company-specific risk be diversified away by investing in both Active Biotech and Swedish Orphan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Active Biotech and Swedish Orphan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Active Biotech AB and Swedish Orphan Biovitrum, you can compare the effects of market volatilities on Active Biotech and Swedish Orphan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Active Biotech with a short position of Swedish Orphan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Active Biotech and Swedish Orphan.
Diversification Opportunities for Active Biotech and Swedish Orphan
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Active and Swedish is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Active Biotech AB and Swedish Orphan Biovitrum in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swedish Orphan Biovitrum and Active Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Active Biotech AB are associated (or correlated) with Swedish Orphan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swedish Orphan Biovitrum has no effect on the direction of Active Biotech i.e., Active Biotech and Swedish Orphan go up and down completely randomly.
Pair Corralation between Active Biotech and Swedish Orphan
Assuming the 90 days trading horizon Active Biotech AB is expected to generate 7.73 times more return on investment than Swedish Orphan. However, Active Biotech is 7.73 times more volatile than Swedish Orphan Biovitrum. It trades about 0.15 of its potential returns per unit of risk. Swedish Orphan Biovitrum is currently generating about -0.14 per unit of risk. If you would invest 19.00 in Active Biotech AB on September 1, 2024 and sell it today you would earn a total of 8.00 from holding Active Biotech AB or generate 42.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Active Biotech AB vs. Swedish Orphan Biovitrum
Performance |
| Timeline |
| Active Biotech AB |
| Swedish Orphan Biovitrum |
Active Biotech and Swedish Orphan Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Active Biotech and Swedish Orphan
The main advantage of trading using opposite Active Biotech and Swedish Orphan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Active Biotech position performs unexpectedly, Swedish Orphan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swedish Orphan will offset losses from the drop in Swedish Orphan's long position.| Active Biotech vs. Cantargia AB | Active Biotech vs. BioArctic AB | Active Biotech vs. Oncopeptides AB | Active Biotech vs. Hansa Biopharma AB |
| Swedish Orphan vs. Kancera AB | Swedish Orphan vs. Cyxone AB | Swedish Orphan vs. Lidds AB | Swedish Orphan vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |